Log in with your email address username.

×

[Articles] Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

VRC5283 was well tolerated and has advanced to phase 2 efficacy testing.

email